Dr. Jehad Abubaker

Dr. Jehad Abubaker obtained his M.Sc. in 1997 from the University of Maryland School of Medicine, Baltimore, MD, USA, specializing in Medical Research and Technology. In 2003, he received his Ph.D. in Molecular Biology from New Mexico State University, USA, and pursued postdoctoral training in the Genetic Department at the same university. Currently, he is the head of the Biochemistry and Molecular Biology Department at the Dasman Diabetes Institute. The goal of the department is to enhance the basic understanding of the metabolic signaling pathways involved in dyslipidemia, oxidative stress, and insulin resistance, which will allow for the development of improved methods for identifying those at risk for T2D, advance the ability to predict complications of the disease, and aid in the design of tailored therapies. He has published approximately 140 manuscripts in high-impact journals such as Nature, Leukemia, Oncogene, Journal of Pathology, and JCEM. His h-index is 43. He has received several awards and fellowships, including the Annual Outstanding Graduate Student Research Award in 2003 from New Mexico State University, USA, the Research Achievement Award of King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia in 2009 and 2010, and the best scientist award at the Dasman Diabetes Institute in 2021.